PVLA – palvella therapeutics, inc. (US:NASDAQ)
Stock Stats
News
High Analyst Confidence on Palvella Therapeutics (PVLA) Following Encouraging Phase 2 Data for QTORIN Rapamycin [Yahoo! Finance]
Assessing Palvella Therapeutics' Valuation After Its Rare Disease Momentum-Driven Surge in 2024 [Yahoo! Finance]
Palvella Therapeutics price target raised to $200 from $120 at Oppenheimer [Yahoo! Finance]
Palvella Therapeutics (NASDAQ:PVLA) was given a new $204.00 price target on by analysts at Canaccord Genuity Group Inc..
Palvella Therapeutics (NASDAQ:PVLA) had its price target raised by analysts at TD Cowen from $97.00 to $133.00. They now have a "buy" rating on the stock.
Form 4 PALVELLA THERAPEUTICS, For: Dec 17 Filed by: Goin Kathleen
Form 144 PALVELLA THERAPEUTICS, Filed by: Goin Kathleen
Form 8-K PALVELLA THERAPEUTICS, For: Dec 15
Form 4 PALVELLA THERAPEUTICS, For: Nov 19 Filed by: Goin Kathleen
Form 144 PALVELLA THERAPEUTICS, Filed by: Goin Kathleen
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.